HanAll Biopharma Appoints Almira Chabi as Chief Medical Officer and Chief Development Officer

/PRNewswire/ -- HanAll Biopharma (KRX: 009420.KS) announced today the appointment of Almira Chabi, M.D. as Chief Medical Officer and Chief Development Officer...

Related Keywords

China ,Seoul ,Soult Ukpyolsi ,South Korea ,Sean Jeong ,Almira Chabi ,Hanall Biopharma ,Prnewswire Hanall Biopharma ,Development Officer ,Genentech ,Cornell University ,University Of Wisconsin ,Wharton Business School Management Program ,Hanall Pharmaceutical International ,Stanford University ,Hanall Biopharma Co Ltd ,All Biopharma ,Chief Medical Officer ,Chief Development Officer ,Chief Medical ,Vice President ,Global Therapeutic Area Head ,Artificial Intelligence Programs ,External Diseases ,Wills Eye Hospital ,Wharton Business School ,